Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Camillo Ribi

Showing results (61-70 of 124) with videos related to

Pageof 13
Sort By:
Revue Medicale Suisse|July 5, 2017
[Eosinophilic gastrointestinal disorders]Konstantin Burgmann, Christophe Brunel, Christine Sempoux, et al.
Frontiers in Allergy|June 30, 2022
Management of Beta-Lactam Antibiotics Allergy: A Real-Life StudySarah Iuliano, Laurence Senn, Laura Moi, et al.
Revue Medicale Suisse|April 2, 2026
[The Role of Nailfold Capillaroscopy in Raynaud's Phenomenon and Autoimmune Diseases]Ludovico Della Vedova, Enrica Porceddu, Lionel Arlettaz, et al.
Scientific Reports|October 31, 2023
Worse cardiovascular and renal outcome in male SLE patientsJelena Mihailovic, Camillo Ribi, Carlo Chizzolini, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|October 24, 2022
Graded-dosing immunization in adults at risk for immediate-type reactions to mRNA SARS-CoV-2 vaccinesFlorian Stehlin, Francesco Tommasini, Véronique Monzambani-Banderet, et al.
Rheumatology (Oxford, England)|April 20, 2018
Prevalence, persistence and clinical correlations of classic and novel antiphospholipid antibodies in systemic lupus erythematosusTess Marchetti, Camillo Ribi, Thomas Perneger, et al.
Joint Bone Spine|December 19, 2015
Low pre-treatment B-cell counts are not a risk factor of infection in patients treated with rituximab for autoimmune diseases: An observational studyIlias Lazarou, Axel Finckh, Lara Fischer, et al.
Revue Medicale Suisse|October 19, 2022
[Janus kinase inhibitors : new perspectives for precision medicine ?]Jérémie Tachet, Alexandre Dumusc, Curdin Conrad, et al.
Frontiers in Immunology|April 8, 2021
Restoration of NK Cell Cytotoxic Function With Elotuzumab and Daratumumab Promotes Elimination of Circulating Plasma Cells in Patients With SLEMorgane Humbel, Florence Bellanger, Natalia Fluder, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
Mitochondrial dysfunction drives natural killer cell dysfunction in systemic lupus erythematosusNatalia W Fluder, Morgane Humbel, Emeline Recazens, et al.
Pageof 13

Showing results (61-70 of 124) with videos related to

Sort By:
Pageof 13
Revue Medicale Suisse|July 5, 2017
[Eosinophilic gastrointestinal disorders]Konstantin Burgmann, Christophe Brunel, Christine Sempoux, et al.
Frontiers in Allergy|June 30, 2022
Management of Beta-Lactam Antibiotics Allergy: A Real-Life StudySarah Iuliano, Laurence Senn, Laura Moi, et al.
Revue Medicale Suisse|April 2, 2026
[The Role of Nailfold Capillaroscopy in Raynaud's Phenomenon and Autoimmune Diseases]Ludovico Della Vedova, Enrica Porceddu, Lionel Arlettaz, et al.
Scientific Reports|October 31, 2023
Worse cardiovascular and renal outcome in male SLE patientsJelena Mihailovic, Camillo Ribi, Carlo Chizzolini, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|October 24, 2022
Graded-dosing immunization in adults at risk for immediate-type reactions to mRNA SARS-CoV-2 vaccinesFlorian Stehlin, Francesco Tommasini, Véronique Monzambani-Banderet, et al.
Rheumatology (Oxford, England)|April 20, 2018
Prevalence, persistence and clinical correlations of classic and novel antiphospholipid antibodies in systemic lupus erythematosusTess Marchetti, Camillo Ribi, Thomas Perneger, et al.
Joint Bone Spine|December 19, 2015
Low pre-treatment B-cell counts are not a risk factor of infection in patients treated with rituximab for autoimmune diseases: An observational studyIlias Lazarou, Axel Finckh, Lara Fischer, et al.
Revue Medicale Suisse|October 19, 2022
[Janus kinase inhibitors : new perspectives for precision medicine ?]Jérémie Tachet, Alexandre Dumusc, Curdin Conrad, et al.
Frontiers in Immunology|April 8, 2021
Restoration of NK Cell Cytotoxic Function With Elotuzumab and Daratumumab Promotes Elimination of Circulating Plasma Cells in Patients With SLEMorgane Humbel, Florence Bellanger, Natalia Fluder, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
Mitochondrial dysfunction drives natural killer cell dysfunction in systemic lupus erythematosusNatalia W Fluder, Morgane Humbel, Emeline Recazens, et al.
Pageof 13